Strategy Adds 24,869 BTC; Plans $1.5B Note Repurchase
Strategy bought 24,869 BTC for about $2.01B, raising holdings to 843,738 BTC as of May 17, 2026, and plans a $1.5B repurchase of 2029 convertible notes.
Strategy added 24,869 bitcoin for approximately $2.01 billion, bringing total holdings to 843,738 BTC as of May 17, 2026. The company disclosed plans to repurchase $1.5 billion in principal of its convertible notes due in 2029 in a filing on May 15.
Michael Saylor announced the most recent purchase on May 18 via X, saying the acquisition averaged about $80,985 per bitcoin. Strategy reported a blended average cost basis of roughly $75,700 per coin and a total bitcoin outlay of about $63.87 billion. The company also reported a 12.6% bitcoin yield year-to-date for 2026, an internal metric it uses to measure BTC accumulation relative to its share base.
Convertible notes allow holders to convert debt into equity under specified conditions. Retiring a portion of those notes reduces the amount of outstanding debt and the potential for future dilution if holders were to convert.
Strategy, formerly known as MicroStrategy, began its concentrated bitcoin accumulation program in 2020. The company has funded purchases through equity offerings and convertible debt. Strategy’s shares trade on Nasdaq under the tickers MSTR and STRC and are used by some investors as equity exposure to bitcoin.
The latest purchase is one of the larger single acquisitions the company has reported in recent months and continues a pattern of periodic buys. At current market prices, Strategy’s 843,738 BTC sit above its reported blended cost basis, resulting in an unrealized gain on the holdings.
The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.







